Abstract

Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin

Author(s): Baker Daniel S, Waldrop Bruce, Arnold John

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 346-349

Download in electronic PDF format for $75
  • Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Page 1
  • Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Page 2
  • Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Page 3
  • Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin Page 4

Abstract

The purpose of this study was to assess the compatibility and stability of drugs commonly found in antibiotic lock solutions (cefotaxime 10 mg/mL plus heparin 5000 IU/mL, vancomycin 25 mcg/mL plus heparin 10 IU/mL, and vancomycin 25 mcg/mL plus ciprofloxacin 2 mg/mL plus heparin 10 IU/ mL). Antibiotic lock solutions under investigation were generated in triplicate from pooled starting samples and maintained at 4°C, 27°C, and 40°C. The antibiotic lock solutions were assessed at various time intervals for chemical stability (specified as retaining greater than 90% of initial drug via high-performance liquid chromatographic analysis) and physical stability (specified as solution free of visible precipitates). Antibiotic lock solutions containing cefotaxime plus heparin remained chemically and physically stable at 4°C throughout the study period. However, samples maintained at higher temperatures had no physical instability but underwent significant chemical degradation as early as 24 hours after the beginning of

Related Keywords

  • cefotaxime
  • vancomycin
  • ciprofloxacin
  • antibiotic lock solutions
  • stability
  • compatibility
  • heparin

Related Categories

  • PARENTERALS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2010
Pg. 346-349
Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin
Author(s): Baker Daniel S, Waldrop Bruce, Arnold John
Nov/Dec 2022
Pg. 522-526
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2007
Pg. 520-524
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
May/Jun 2020
Pg. 238-241
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Author(s): Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa
Jul/Aug 2016
Pg. 347-350
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Author(s): Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
Sep/Oct 2010
Pg. 421
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 456-459
Testing the Long-Term Stability of Vancomycin Ophthalmic Solution
Author(s): McLellan Christine, Ngo Van, Pasedis Sophia, Dohlman Claes H
Mar/Apr 1997
Pg. 123-124
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs
Author(s): Allen Loyd V Jr, Stiles M Lou
Jan/Feb 2016
Pg. 56
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 159-163
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Jul/Aug 2022
Pg. 330-335
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Author(s): Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2011
Pg. 508
Vancomycin 31-mg/mL Ophthalmic Solution
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 60
Vancomycin HCl and Heparin Sodium Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2016
Pg. 41-45
Formulation and Stability of Solutions
Author(s): Akers Michael J
Jul/Aug 2001
Pg. 323-324
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Author(s): Quay Irene, Tan Edward
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 167-169
Stability of Vancomycin in SyrSpend SF
Author(s): Whaley Paul A, Voudrie Mark A II